BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Human chorionic gonadotropin
,
Quercetin
,
rs2230926
,
TGFB1
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
APOC3;jsessionid=0461AE2E20178A98426D7C787E5404F0
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal lung
Skeletal muscle
Pharyngeal mucosa
Mammary gland
Kidney cortex
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.
Simultaneous Quantification of Apolipoprotein C-III O-Glycoforms by Protein-MRM.
Role of APOC3 3238C/G polymorphism in HIV-associated neurocognitive disorder.
Apolipoprotein C3 and circulating mediators of preadipocyte proliferation in states of lipodystrophy…
Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for APOC3;jsessionid=0461AE2E20178A98426D7C787E5404F0
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ